DJIA 16,919.59 80.85 0.48%
NASDAQ 4,527.51 19.20 0.43%
S&P 500 1,981.60 9.86 0.50%
market minute promo

GlaxoSmithKline (NYSE: GSK)

47.35 -0.11 (-0.23%)

REAL-TIME: Last trade at

Extended Hours: $47.42 $0.07 (0.15%)
Quote as of (NYSE)



company name or ticker

Recent Quotes

GSK $47.35 -0.23%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $47.06
Previous Close $47.46
Daily Range $46.97 - $47.42
52-Week Range $46.01 - $56.73
Market Cap $113.7B
P/E Ratio 16.31
Dividend (Yield) $2.59 (5.6%)
Ex-Dividend Date
Dividend Pay Date
08/06/14
10/02/14
Volume 3,706,160
Average Daily Volume 4,227,980
Current FY EPS $3.20

Sector

Healthcare

Industry

Drugs

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary Rss Feed

Ebola Vaccine and Inhaled Insulin Incoming

Biotech partnerships, an IPO that wasn't, and how big data is fighting Ebola.

Yes, Call it a Comeback: Amicus Fabry Drug Posts Big Study Win

GlaxoSmithKline: To Buy Or Not To Buy?

Kindred 30.33% Upside Paced Healthcare August Dividend Dogs

Sinopharm, Biostar, Lilly Rise on Medical Modernization in China

Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

Why GlaxoSmithKline Is A Tempting Buy

Dynavax Is More Than Just HEPLISAV

Moving Average Crossover Alert: GlaxoSmithKline (GSK) - Tale of the Tape

3 Value Stocks Worth Buying

After being crushed by weak earnings reports, are these three value stocks now at a price too enticing to pass up?

See More GSK News...

GSK's Top Competitors

GSK $47.35 (-0.23%)
Current stock: GSK
JNJ $102.96 (0.25%)
Current stock: JNJ
NVS $88.63 (1.29%)
Current stock: NVS
RHHBY $36.64 (0.71%)
Current stock: RHHBY